Skip to main content

Find Clinical Trials

Home
Conditions
Neutropenia

Clinical trial condition

Neutropenia

Explore clinical trials studying Neutropenia. Study availability and eligibility vary by location and protocol.

222 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Neutropenia trial results

Completed

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

NCT00911170

Conditions: Agranulocytosis, Body Temperature Changes, Cancer, +28 more
Locations: Research Site Muscle Shoals, Alabama, United States

Research Site Jonesboro, Arkansas, United States

Research Site Anaheim, California, United States

Research Site Beverly Hills, California, United States

View all 154 locations

View Trial Details

Completed

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

NCT00771810

Conditions: Adnexal Diseases, Agranulocytosis, Anemia, +25 more
Locations: University of Southern Alabama Mitchell Cancer Institute Mobile, Alabama, United States

USC - LAC Medical Center Los Angeles, California, United States

University of California - Irvine, Chao Family Comprehensive Cancer Center Orange, California, United States

Rush University Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

NCT01516736

Conditions: Agranulocytosis, Breast Cancer, Breast Diseases, +12 more
Locations: Sandoz Investigational Site Hot Springs, Arkansas, United States

Sandoz Investigational Site Jonesboro, Arkansas, United States

Sandoz Investigational Site Corona, California, United States

Sandoz Investigational Site Wichita, Kansas, United States

View all 53 locations

View Trial Details

Completed

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

NCT03246009

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations: Chinese Academy of Medical Sciences Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

NCT01735175

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +13 more
Locations: Sandoz Investigational Site Ijuí, Brazil

Sandoz Investigational Site Lajeado, Brazil

Sandoz Investigational Site Santo André, Brazil

Sandoz Investigational Site Andhra Pradesh, India

View all 41 locations

View Trial Details

Completed

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

NCT00260689

Conditions: Agranulocytosis, Anemia, Anemia, Aplastic, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia

NCT01193283

Conditions: Agranulocytosis, Anemia, Anemia, Aplastic, +13 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

NCT00335478

Conditions: Agranulocytosis, Body Temperature Changes, Cytopenia, +13 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy

NCT02679443

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Agranulocytosis, +19 more
Locations: PGIMER Chandigarh, India

View Trial Details

Completed

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

NCT00686543

Conditions: Acute Myelogenous Leukemia, Agranulocytosis, Bacterial Infections and Mycoses, +14 more
Locations: Not specified

View Trial Details